With today's current focus on patient safety and medication administration, the ISMP and JCAHO have identified several consistently problematic areas for PCA use: PCA has been used successfully with ...

Complications other than urinary incontinence or erectile dysfunction occur frequently following treatment for prostate cancer (PCa), according to new findings published online in The Lancet Oncology.

Nearly one quarter of men with stage IV prostate cancer (PCa) receive no treatment for the malignancy, data show. Eberechukwu Onukwugha, PhD, of the University of Maryland School of Pharmacy in ...

A recent study suggests that patients with high-risk prostate cancer (PCa) in need of renal transplantation should receive cancer treatment before their transplants, as surgery and radiation treatment ...

Targeting prostate cancer (PCa) neuroendocrine (NE) cells via inhibition of the C-X-C motif chemokine receptor 2 (CXCR2) is an androgen receptor (AR)-independent therapeutic strategy that can improve ...

The authors noted that the indications of HIFU and its advantages have not been fully established; however, previous studies have explored its usefulness as a treatment for localized PCa and found it ...

Consensus on Treatment and Follow-Up for Biochemical Recurrence in Castration-Sensitive Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries ...

Several novel therapies for castration-resistant prostate cancer (CRPC) have been approved with randomized phase III studies with continuing observational research either planned or ongoing.

Patient-controlled analgesia (PCA) was introduced into hospitals in the 1970s to improve the quality of postoperative pain control, and since then it has been a popular option. Patients like PCA and ...